Evaluation of glucagon secretion in type 2 diabetes

Evaluation of glucagon secretion in type 2 diabetes - Type 2 diabetes and glucagon

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033387

Enrollment

Registered

2018-07-13

Start date

2018-07-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed type 2 diabetes by diabetologists.

Exclusion criteria

Exclusion criteria: Patients uncontrolled fasting glucose at 80-180 mg/dL. Patients with cerebrovascular disease and/or cardiovascular disease. Pregnant women. Lactating women.

Design outcomes

Primary

Measure	Time frame
Evaluation of glucagon secretion when administered diet	—

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Hospital Endocrinology and Metabolism

holy197741@me.com0958197200

Outcome results